Overview of Stemness

Our CEO, Wendy Blosser, provides a quick primer on one of the important foundations of the proprietary StemPrintER test, tumor “stemness.”

Breast Cancer Opportunity

Genomics are broadly utilized in cancer- our CEO, Wendy Blosser, explains our mission at AccuStem and the market opportunity for StemPrintER in breast cancer.

AccuStem’s Leadership Team

Accustem’s leadership comprises successful and experienced veterans from the diagnostics space. Our CEO, Wendy Blosser, provides a brief introduction to the team.

AccuStem Agrees to Joint Collaboration with University Hospitals

AccuStem Sciences Inc CEO Wendy Blosser joined Steve Darling from Proactive to share more details about the company that started as a spinout of Tiziana Life Sciences to focus on three primary healthcare verticals including pharmaceuticals, diagnostics or devices.